Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Lamb who wrote (2559)	5/18/1998 1:13:00 PM
From: Uncle Frank	Read Replies (1) \| Respond to of 9523

If we can't stop India from making nuclear weapons, how can we expect Pfizer to keep them from making sildenafil citrate?

To: Jim Lamb who wrote (2559)	5/18/1998 1:27:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

This is another form of counterfeit drug, though they are saying they have "developed a new process to make sildenafil citrate"; but we expect this to happen, since most Asian countries offer no patent protection. Read the news about counterfeit Prozac in China (4 companies making "generic" versions of Prozac)? Even the government is on the side of the counterfeiters. If it's that easy to develop a new process to make sildenafil citrate. Glaxo, Merck, LLY and all the other big pharmaceuticals and biotechs would already have done it. Viagra has only been on the market for a little over 1 month, which means that it is only during these past few months that the world knows how ludricous the sales of this drug will be, and this company in India already developed this "new process" in a few months' time? Give me a break.